Heart : official journal of the British Cardiac Society
-
Randomized Controlled Trial Multicenter Study
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
We compared the haemodynamic effects of riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy in the Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase-Stimulator Trial 1 study. ⋯ Riociguat improved haemodynamics in patients with inoperable CTEPH or persistent/recurrent CTEPH.